Subscribe
istock-866149824natee-meepian
Natee Meepian / iStockphoto.com
29 August 2018Americas

Purdue settles another OxyContin patent suit

Purdue Pharma has settled another patent dispute involving pain drug OxyContin (oxycodone), just weeks after a suit against generics company Amneal Pharmaceuticals came to an end.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Purdue and Amneal OxyContin clash ends
15 August 2018   A patent dispute over a generic version of Purdue Pharma’s drug OxyContin (oxycodone), which is used to treat moderate to severe pain, has come to an end.
Americas
Purdue continues OxyContin patent battle
10 October 2017   Purdue Pharma has sued Collegium Pharmaceutical, in the latest development in a continuing patent infringement dispute centring on Purdue’s painkiller drug OxyContin.


Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Americas
Purdue and Amneal OxyContin clash ends
15 August 2018   A patent dispute over a generic version of Purdue Pharma’s drug OxyContin (oxycodone), which is used to treat moderate to severe pain, has come to an end.
Americas
Purdue continues OxyContin patent battle
10 October 2017   Purdue Pharma has sued Collegium Pharmaceutical, in the latest development in a continuing patent infringement dispute centring on Purdue’s painkiller drug OxyContin.

More on this story

Americas
Purdue and Amneal OxyContin clash ends
15 August 2018   A patent dispute over a generic version of Purdue Pharma’s drug OxyContin (oxycodone), which is used to treat moderate to severe pain, has come to an end.
Americas
Purdue continues OxyContin patent battle
10 October 2017   Purdue Pharma has sued Collegium Pharmaceutical, in the latest development in a continuing patent infringement dispute centring on Purdue’s painkiller drug OxyContin.

More features

Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’
Powell Gilbert launches Düsseldorf office with leading patent litigator
Startups toolkit: Why investors want more than patents
J&J fends off generic schizophrenia drug bids
Kilpatrick adds ‘seasoned litigator’ as trademark partner
WATCH: An update on EPO Board of Appeal strategy for 2025 and beyond
Startup challenges rival over brain monitoring tech at ITC
UKIPO rejects Boehringer’s SPC for horse inhaler